منابع مشابه
[Use of glaucoma medications during pregnancy and breastfeeding].
There is an abundance of literature on treatment options for glaucoma in pregnant women. Even so, the doubts about the safest medical treatment and the adequate management of glaucoma during pregnancy have not yet been resolved.1 In a survey published in 2007 by Eye, 26% of respondents referred having treated a pregnant woman with glaucoma. This theoretically infrequent situation is becoming in...
متن کاملGlaucoma Surgery in Pregnancy: A Case Series and Literature Review
AbstractGlaucoma management in pregnant patients is a real challenge, especially when the glaucoma is not controlled with medications. We report the results of 6 incisional glaucoma surgeries for the management of medically uncontrolled glaucoma patients during pregnancy. This retrospective, case series was conducted on the 6 eyes of 3pregnant patients with uncontrolled glaucoma using maximum t...
متن کاملCost analysis of glaucoma medications.
PURPOSE To provide patients and health care providers with calculated yearly costs of topical glaucoma medications. DESIGN Prospective, experimental, laboratory study. METHODS Using the average wholesale price and common dosing patterns, we calculated the theoretical yearly cost of glaucoma medications. RESULTS Calculated yearly cost ranged from $150.81 for generic timolol maleate 0.5% (F...
متن کاملFixed Combinations of Glaucoma Medications.
The first line treatment in the management of glaucoma is topical medical therapy. Many patients with glaucoma require multiple medications for adequate intraocular pressure control. For patients who need multi-dose regimens to control intraocular pressure, fixed combinations offer convenience, efficacy and safety. This review summarizes the role, efficacy, mechanism of action and indications f...
متن کاملNew classes of glaucoma medications.
PURPOSE OF REVIEW To discuss recent advances in the medical management of glaucoma and to highlight future medical therapies currently in development. RECENT FINDINGS In 1996, latanoprost (Xalatan) was approved in the United States as a new chemical entity and new class (prostaglandin analogs) for the topical treatment of ocular hypertension and glaucoma. In the period from the late 1990s-201...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oman Journal of Ophthalmology
سال: 2018
ISSN: 0974-620X
DOI: 10.4103/ojo.ojo_212_2017